ERECTILE DYSFUNCTION

被引:11
作者
CARRIER, S [1 ]
ZVARA, P [1 ]
LUE, TF [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT UROL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1016/S0889-8529(18)30066-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erectile dysfunction is the inability to maintain an erect penis with sufficient rigidity for vaginal penetration and sexual satisfaction. It is different from loss of libido, premature ejaculation, or absence of orgasm. It is an age-dependent disorder with an incidence of 1.9% at 40 years and up to 25% at 65 years.(15) Moreover, certain diseases such as diabetes mellitus predispose the patient to erectile dysfunction with reported incidence as high as 50%.(24) Innovative laboratory and clinical research in the hemodynamics, neurophysiology, and pharmacology of erection have greatly improved our understanding of the pathophysiology of erectile dysfunction. To date, organic erectile dysfunction has been most frequently attributed to neurogenic and vasculogenic abnormalities. In most of the cases, however, the etiology of the disease is complex and involves more than one cause. Because intracavernous injection therapy, in which the medication is injected directly into the corpus cavernosum, is successful in most patients regardless of the cause of the impotence, the physician is often placed in the position of treating the symptom while overlooking the cause of erectile dysfunction. We believe that a basic workup including a detailed history, physical examination, and blood tests should be obtained in every patient. Additional tests can then be individualized according to the patient's general health, expectations, and goal. This article provides an overview of our approach.
引用
收藏
页码:773 / 782
页数:10
相关论文
共 35 条
  • [1] ABRAMOWICZ M, 1987, MED LETT, V29, P65
  • [2] CHANGES IN ERECTILE RESPONSIVENESS DURING ANDROGEN REPLACEMENT THERAPY
    BANCROFT, J
    WU, FCW
    [J]. ARCHIVES OF SEXUAL BEHAVIOR, 1983, 12 (01) : 59 - 66
  • [3] CLONED AND EXPRESSED NITRIC-OXIDE SYNTHASE STRUCTURALLY RESEMBLES CYTOCHROME-P-450 REDUCTASE
    BREDT, DS
    HWANG, PM
    GLATT, CE
    LOWENSTEIN, C
    REED, RR
    SNYDER, SH
    [J]. NATURE, 1991, 351 (6329) : 714 - 718
  • [5] BROCK G, 1992, MONOGR UROL, V13, P97
  • [6] BUFFUM J, 1986, J PSYCHOACTIVE DRUGS, V18, P97
  • [7] NITRIC-OXIDE AS AN INHIBITORY NONADRENERGIC NONCHOLINERGIC NEUROTRANSMITTER
    BULT, H
    BOECKXSTAENS, GE
    PELCKMANS, PA
    JORDAENS, FH
    VANMAERCKE, YM
    HERMAN, AG
    [J]. NATURE, 1990, 345 (6273) : 346 - 347
  • [8] CHARACTERISTICS AND MECHANISMS OF HIGH-GLUCOSE INDUCED OVEREXPRESSION OF BASEMENT-MEMBRANE COMPONENTS IN CULTURED HUMAN ENDOTHELIAL-CELLS
    CAGLIERO, E
    ROTH, T
    ROY, S
    LORENZI, M
    [J]. DIABETES, 1991, 40 (01) : 102 - 110
  • [9] CARATI CJ, 1987, J PHYSL, V384, P535
  • [10] PATHOPHYSIOLOGY OF ERECTILE DYSFUNCTION
    CARRIER, S
    BROCK, G
    KOUR, NW
    LUE, TF
    [J]. UROLOGY, 1993, 42 (04) : 468 - 481